Stock listing
NASDAQ:HSCS HeartSciences Inc. Stock
Home listing (NASDAQ) of HeartSciences Inc.
Follow HeartSciences Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:HSCS
$1.81 USD -0.29 (-13.8%)
Close on Nov 20, 2026
- Day range
- $1.77 – $2.05 USDNov 20, 2026
- Volume
- 174,596 sharesNov 20, 2026
- Market cap
- $8.99M USDAt the close on Nov 20, 2026 · price × 4.97M shares outstanding
- 52-week range
- $1.63 – $5.25 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $603,584 USDMedian day 98,400 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:HSCS · Home | $1.81 USD | -0.29 (-13.8%) | 174,596 | $1.96 | $2.05 | $1.77 | $2.10 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:HSCS · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.81 | -0.29 | -13.8% | $1.96 | $2.05 | $1.77 | 174,596 | |
| $2.10 | +0.04 | +1.9% | $2.13 | $2.15 | $2.00 | 15,659 | |
| $2.06 | -0.02 | -1.0% | $2.12 | $2.19 | $2.05 | 17,544 | |
| $2.08 | -0.045 | -2.1% | $2.13 | $2.175 | $2.05 | 29,846 | |
| $2.125 | -0.135 | -6.0% | $2.21 | $2.31 | $2.09 | 33,406 | |
| $2.26 | -0.035 | -1.5% | $2.205 | $2.33 | $2.20 | 86,303 | |
| $2.295 | -0.10 | -4.2% | $2.525 | $2.525 | $2.06 | 181,936 | |
| $2.395 | -0.315 | -11.6% | $2.69 | $2.82 | $2.04 | 230,194 | |
| $2.71 | -0.12 | -4.2% | $2.78 | $2.94 | $2.60 | 77,705 | |
| $2.83 | +0.16 | +6.0% | $2.75 | $3.03 | $2.75 | 76,388 | |
| $2.67 | -0.43 | -13.9% | $3.06 | $3.06 | $2.62 | 81,153 | |
| $3.10 | +0.15 | +5.1% | $3.02 | $3.26 | $3.02 | 100,553 | |
| $2.95 | -0.04 | -1.3% | $3.156 | $3.156 | $2.88 | 60,630 | |
| $2.99 | -0.32 | -9.7% | $3.37 | $3.37 | $2.97 | 69,839 | |
| $3.31 | -0.30 | -8.3% | $3.57 | $3.57 | $3.31 | 54,480 | |
| $3.61 | +0.24 | +7.1% | $3.323 | $3.61 | $3.25 | 75,784 | |
| $3.37 | +0.09 | +2.7% | $3.27 | $3.415 | $3.182 | 25,569 | |
| $3.28 | +0.10 | +3.1% | $3.182 | $3.38 | $3.15 | 110,558 | |
| $3.18 | +0.04 | +1.3% | $3.14 | $3.274 | $3.01 | 130,452 | |
| $3.14 | -0.03 | -0.9% | $3.17 | $3.22 | $3.07 | 21,800 | |
| $3.17 | -0.39 | -11.0% | $3.41 | $3.445 | $3.11 | 98,400 | |
| $3.56 | +0.43 | +13.7% | $3.20 | $3.68 | $3.20 | 236,000 | |
| $3.13 | +0.06 | +2.0% | $3.02 | $3.32 | $3.00 | 42,800 | |
| $3.07 | +0.05 | +1.7% | $2.97 | $3.16 | $2.93 | 85,400 | |
| $3.02 | -0.16 | -5.0% | $3.18 | $3.27 | $3.00 | 129,100 | |
| $3.18 | +0.16 | +5.3% | $2.95 | $3.239 | $2.89 | 71,600 | |
| $3.02 | -0.07 | -2.3% | $3.10 | $3.165 | $2.951 | 85,700 | |
| $3.09 | -0.21 | -6.4% | $3.36 | $3.42 | $3.045 | 90,700 | |
| $3.30 | +0.12 | +3.8% | $3.19 | $3.37 | $3.09 | 58,000 | |
| $3.18 | +0.14 | +4.6% | $3.25 | $3.44 | $3.15 | 109,300 | |
| $3.04 | -0.45 | -12.9% | $3.40 | $3.435 | $3.02 | 152,700 | |
| $3.49 | -0.28 | -7.4% | $3.67 | $3.815 | $3.49 | 75,300 | |
| $3.77 | -0.59 | -13.5% | $3.79 | $3.88 | $3.368 | 599,700 | |
| $4.36 | +0.06 | +1.4% | $4.15 | $4.63 | $4.15 | 2,136,900 | |
| $4.30 | +0.41 | +10.5% | $3.87 | $4.44 | $3.87 | 178,000 | |
| $3.89 | -0.29 | -6.9% | $4.15 | $4.24 | $3.80 | 134,300 | |
| $4.18 | +0.13 | +3.2% | $4.14 | $4.36 | $4.11 | 72,900 | |
| $4.05 | -0.38 | -8.6% | $4.40 | $4.48 | $3.97 | 136,800 | |
| $4.43 | -0.30 | -6.3% | $4.65 | $4.65 | $4.29 | 99,700 | |
| $4.73 | +0.10 | +2.2% | $4.78 | $5.00 | $4.66 | 97,900 | |
| $4.63 | +0.11 | +2.4% | $4.64 | $4.75 | $4.23 | 125,900 | |
| $4.52 | -0.09 | -2.0% | $4.56 | $5.03 | $4.45 | 179,700 | |
| $4.61 | -0.07 | -1.5% | $4.76 | $5.21 | $4.55 | 264,400 | |
| $4.68 | -0.52 | -10.0% | $5.25 | $5.25 | $4.62 | 247,400 | |
| $5.20 | +0.36 | +7.4% | $4.79 | $5.21 | $4.68 | 174,400 | |
| $4.84 | +1.05 | +27.7% | $3.90 | $4.89 | $3.805 | 386,200 | |
| $3.79 | +0.35 | +10.2% | $3.45 | $3.94 | $3.43 | 89,200 | |
| $3.44 | -0.10 | -2.8% | $3.50 | $3.50 | $3.25 | 65,700 | |
| $3.54 | +0.15 | +4.4% | $3.39 | $3.60 | $3.33 | 81,000 | |
| $3.39 | -0.12 | -3.4% | $3.40 | $3.69 | $3.31 | 100,700 | |
| $3.51 | -0.61 | -14.8% | $3.86 | $4.015 | $3.38 | 222,000 | |
| $4.12 | +0.04 | +1.0% | $4.31 | $4.32 | $3.88 | 124,700 | |
| $4.08 | +0.35 | +9.4% | $3.98 | $4.35 | $3.905 | 288,900 | |
| $3.73 | +0.37 | +11.0% | $3.34 | $3.83 | $3.21 | 179,600 | |
| $3.36 | +0.35 | +11.6% | $3.12 | $3.45 | $2.96 | 176,600 | |
| $3.01 | -0.11 | -3.5% | $3.12 | $3.189 | $3.00 | 25,400 | |
| $3.12 | -0.03 | -1.0% | $3.19 | $3.28 | $3.095 | 69,700 | |
| $3.15 | +0.12 | +4.0% | $3.01 | $3.20 | $2.95 | 56,000 | |
| $3.03 | -0.09 | -2.9% | $3.09 | $3.14 | $2.90 | 45,700 | |
| $3.12 | +0.13 | +4.3% | $2.94 | $3.25 | $2.90 | 155,900 | |
| $2.99 | -0.01 | -0.3% | $2.90 | $3.03 | $2.825 | 81,400 | |
| $3.00 | +0.24 | +8.7% | $2.80 | $3.04 | $2.70 | 96,600 | |
| $2.76 | -0.04 | -1.4% | $2.91 | $3.20 | $2.70 | 718,100 | |
| $2.80 | +0.29 | +11.6% | $2.53 | $2.87 | $2.47 | 198,800 | |
| $2.51 | -0.035 | -1.4% | $2.49 | $2.617 | $2.37 | 231,100 |
Splits
1 split · NASDAQ:HSCS · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-100 | Consolidation |
- Ticker
- NASDAQ:HSCS
- Asset type
- Stock
- Sector
- Health care
- Industry
- Health care services
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 20, 2026
HeartSciences Shareholders Approve Proposed Business Combination with Fortitude Mining
Latest deck · Jun 23, 2026
Merger or Acquisition (June 2026)
Merger or acquisition · 35 slides
Latest news
HeartSciences Shareholders Approve Proposed Business Combination with Fortitude Mining
Nov 20, 2026
Closed $1.81 (-13.8%) on Nov 20, 2026
HeartSciences Shareholders Approve Business Combination with Fortitude
Nov 20, 2026
Closed $1.81 (-13.8%) on Nov 20, 2026
HeartSciences Files Definitive Proxy Statement for Proposed Business Combination with Fortitude Mining
Oct 21, 2026
Closed $3.56 (+13.7%) on Oct 21, 2026
HeartSciences Receives FDA 510(k) Clearance for its MyoVista® wavECGTM Device
Oct 6, 2026
Closed $3.77 (-13.5%) on Oct 6, 2026
HeartSciences Reports Fiscal First Quarter 2027 Financial Results and Provides Business Update
Sep 15, 2026
Closed $3.44 (-2.8%) on Sep 15, 2026
Fortitude Invests $1.0 Million in HeartSciences at a 22% Premium with No Adjustment to the Merger Consideration
Aug 19, 2026
Closed $2.55 (+19.5%) on Aug 19, 2026
HeartSciences Files Preliminary Proxy Statement for Business Combination with Fortitude Mining Holdings, Provides Business Update and Reports Fiscal 2026 Financial Results
Jul 30, 2026
Closed $2.08 (-3.7%) on Jul 30, 2026
HeartSciences Files Its Fiscal 2026 Annual Report on Form 10-K
Jul 23, 2026
Closed $2.39 (-2.0%) on Jul 24, 2026
HeartSciences Inc. on 6ix
- Sector
- Health care
- Industry
- Health care services
- News releases
- 23 in the last 12 months · 77 in all · newest Nov 20, 2026 · oldest 2022
- Decks
- 4 decks · latest Jun 23, 2026
Where HeartSciences Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:HSCS · Home listing · This page | NASDAQ | United States | USD |
| BOATS:HSCS | BOATS | United States | USD |
Valuation
EV/sales 1,984× against a median of 3.3×: the highest of 11 Health care services companies shown. Statements: 4 quarters to Jul 31, 2026 · price Nov 20, 2026
- Enterprise value
- $8.96M USD
- P/E
- Loss
- EV/sales
- 1,984×
- EV/EBITDA
- No depreciation figure on 6ix yet
- Price/book
- Negative equity
- Gross margin
- 60.9%
- Operating margin
- Revenue too small
- Net margin
- Revenue too small
- Debt to equity
- Negative equity
- Beta vs S&P 500
- 1.23
Health care services: the 10 companies nearest in size, of 419 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| HeartSciences Inc. · NASDAQ:HSCS | US$8.99M | US$8.96M | n/a | 1,984× | n/a | n/a | n/a | n/a | 1.23 |
| Morefield Group N.V. · EURONEXT:MORE | US$10.12M | US$75.51M | 2.2× | 0.4× | 2.6× | 0.4× | 2.6% | 3.1× | n/a |
| Concord Medical Services Holdings Ltd. · NYSE:CCM | US$9.99M | US$509.8M | n/a | 7.4× | n/a | n/a | −20.2% | n/a | 0.49 |
| Vidavo SA · ATHEX:VIDAVO | US$9.78M | US$8.25M | 15.0× | 3.5× | 9.2× | 4.1× | 27.4% | 0.0× | n/a |
| AIML Innovations Inc · CSE:AIML | US$9.68M | US$11.23M | n/a | 369× | n/a | n/a | n/a | n/a | 0.33 |
| UCrest Bhd · MYX:UCREST | US$9.05M | US$6.78M | 138× | 2.0× | 34.7× | 0.9× | 1.9% | 0.0× | n/a |
| PainChek Ltd · ASX:PCK | US$8.86M | US$7.71M | n/a | 3.1× | n/a | n/a | −238.8% | n/a | n/a |
| Good Fellow Healthcare Holdings Limited · HKEX:8143 | US$8.53M | US$6.81M | n/a | 2.7× | n/a | 8.2× | −62.4% | 0.1× | n/a |
| KDA Group Inc. · TSXV:KDA | US$8.51M | US$8.34M | n/a | 28.6× | n/a | 2.0× | n/a | 0.0× | -0.76 |
| InteliCare Holdings Limited · ASX:ICR | US$8.05M | US$8.25M | n/a | 13.0× | n/a | n/a | −234.6% | n/a | n/a |
| SEI Medical Public Co., Ltd. · SET:SEI | US$7.91M | US$4.28M | 8.7× | 0.3× | 2.5× | 0.9× | 7.5% | 0.0× | n/a |
| Median of the others | US$8.96M | US$8.25M | 11.9× | 3.3× | 5.9× | 1.5× | −9.1% | 0.0× | 0.33 |
Forecasts
1 buy · Analysts' consensus from EODHD, read Nov 10, 2026. Not 6ix's view and not investment advice.
- Price target
- 12.00 USD · Analysts' mean
- EPS, year to Apr 2027
- -2.46 · 1 analyst
- Revenue, year to Apr 2027
- 17.1K · 1 analyst
Team and board
Officers
| Officer | Role |
|---|---|
| Andrew Simpson | Chairman and CEO / Board Member |
| Danielle Watson | Chief Financial Officer |
| Aaron Peterson | VP, Research & Development |
| Isabella Schmitt | VP, Clinical & Regulatory Affairs |
| Jason Domask | VP of Software Engineering & MyoVista Insights™ Product Owner |
Board
| Director | Role |
|---|---|
| Andrew Simpson | Chairman and CEO / Board Member |
| Brian Szymczak | Board Member |
| Bruce Bent | Board Member |
| David R. Wells | Board Member |
Events
- Next results
- Dec 21, 2026 (expected)
| Quarter | Results | Share move |
|---|---|---|
| Q1 2027 | Sep 14, 2026 · After close | −2.8% |
| Q4 2026 | Jul 23, 2026 · After close | −2.0% |
| Q3 2026 | Mar 16, 2026 · After close | −0.4% |
| Q2 2026 | Dec 15, 2025 · After close | −6.5% |
| Q1 2026 | Sep 11, 2025 · After close | −10.0% |
| Q4 2025 | Jul 24, 2025 · After close | +0.3% |
| Q3 2025 | Mar 13, 2025 · After close | −3.6% |
| Q2 2025 | Dec 16, 2024 · After close | 0.0% |
| Q1 2025 | Sep 12, 2024 · After close | +9.0% |
| Q4 2024 | Jul 17, 2024 | −3.5% |
All 18 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q3 2024 | Mar 14, 2024 · After close | +1.6% |
| Q2 2024 | Dec 14, 2023 · After close | +12.0% |
| Q1 2024 | Sep 14, 2023 · After close | +3.9% |
| Q4 2023 | Jul 19, 2023 · Before open | −5.3% |
| Q3 2023 | Mar 16, 2023 · After close | +9.9% |
| Q2 2023 | Dec 15, 2022 · After close | −1.5% |
| Q1 2023 | Sep 12, 2022 · After close | +4.8% |
| Q4 2022 | Jul 29, 2022 · After close | +5.1% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Merger or Acquisition (June 2026) | Merger or acquisition | 35 slides | Jun 23, 2026 |
| Merger or Acquisition (June 2026) | Merger or acquisition | 11 slides | Jun 23, 2026 |
| Merger or Acquisition (June 2026) | Merger or acquisition | 35 slides | June 2026 |
| Heart Test Laboratories — IPO Roadshow (June 2022) | IPO roadshow | 25 slides | Jun 6, 2022 |
Financings
| Raise | Date |
|---|---|
| Private placement of shares of common stock Closed: US$1M in the latest tranche · US$2.43 a share Buyers: Fortitude Mining Holdings, Inc. (approximately $1.0 million of shares of common stock) Use of proceeds: Working capital and strengthening the balance sheet ahead of the proposed business combination | Sep 15, 2026 |
| At-the-market programme of common stock Tranche closed: US$1.2M raised | Sep 15, 2026 |
Open Financings · Read by 6ix AI from the company's releases
IPO
Went public as Heart Test Laboratories, Inc. Priced at US$4.25 a unit on Jun 17, 2022.
- Price
- US$4.25 a unit
- Units offered
- 1,500,000 units
- Offering size
- US$6.4 million
- Underwriter
- The Benchmark Company
- Units delivered
- On or about Jun 17, 2022
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Feb 28, 2022 |
| Filed publicly | May 17, 2022 |
| Amended 3 times | Newest Jun 13, 2022 |
| Shares registered with an exchange | Jun 14, 2022 |
| Declared effective by the SEC | Jun 14, 2022 |
| Final prospectus, with the price | Jun 17, 2022 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Jun 17, 2022 |
| EFFECT · Notice that a registration is effective | Jun 14, 2022 |
| CERT · Exchange's certificate of listing | Jun 14, 2022 |
| 8-A12B · Registration of shares for listing on an exchange | Jun 14, 2022 |
| CORRESP · Letter to the SEC | Jun 13, 2022 |
| CORRESP · Letter to the SEC | Jun 13, 2022 |
| S-1/A · Registration statement, amended | Jun 13, 2022 |
| CORRESP · Letter to the SEC | Jun 10, 2022 |
| CORRESP · Letter to the SEC | Jun 10, 2022 |
| S-1/A · Registration statement, amended | Jun 10, 2022 |
All 22 filings
| Filing | Filed |
|---|---|
| UPLOAD · Letter from the SEC | Jun 9, 2022 |
| FWP · Free writing prospectus | Jun 6, 2022 |
| CORRESP · Letter to the SEC | Jun 6, 2022 |
| S-1/A · Registration statement, amended | Jun 6, 2022 |
| UPLOAD · Letter from the SEC | Jun 1, 2022 |
| CORRESP · Letter to the SEC | May 17, 2022 |
| S-1 · Registration statement | May 17, 2022 |
| UPLOAD · Letter from the SEC | May 11, 2022 |
| DRS/A · Draft registration statement, amended | Apr 20, 2022 |
| DRSLTR · Letter to the SEC with a draft | Apr 19, 2022 |
| UPLOAD · Letter from the SEC | Apr 4, 2022 |
| DRS · Draft registration statement | Feb 28, 2022 |
Open IPO · From the cover of the final prospectus (424B4) filed Jun 17, 2022
Financials
Annual, in USD
Income statement
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 4.32K | 4.35K | 18.6K | 5.15K | 14.4K |
| Cost of revenue | 1.77K | 1.88K | 6.08K | 2.80K | 7.89K |
| Gross profit | 2.55K | 2.47K | 12.5K | 2.35K | 6.48K |
| Research and development | 2.84M | 4.39M | 2.88M | 2.46M | 3.00M |
| Selling, general and administrative | 5.58M | 3.97M | 3.44M | 3.65M | 1.71M |
| Operating income | -8.41M | -8.35M | -6.31M | -6.11M | -4.71M |
| Depreciation and amortization | 27.8K | 37.6K | 27.9K | 26.9K | 26.6K |
| EBITDA | -8.39M | -8.31M | -6.28M | -6.09M | -4.68M |
| Interest expense | 753.0K | 500.5K | 354.1K | 243.2K | 371.6K |
| Income tax | 0 | 0 | |||
| Net income | -9.14M | -8.77M | -6.61M | -6.35M | -4.83M |
| Earnings per share, basic | -3.48 | -9.34 | -18.74 | -80.00 | -1.45 |
| Earnings per share, diluted | -9.34 | -18.74 | -80.00 | -1.45 |
Balance sheet
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Cash and equivalents | 1.66M | 1.10M | 5.81M | 1.66M | 918.3K |
| Receivables | 4.35K | 2.32K | |||
| Inventory | 655.6K | 650.3K | 629.2K | 676.4K | 674.1K |
| Current assets | 2.58M | 2.17M | 7.35M | 2.70M | 1.93M |
| Property, plant and equipment | 39.3K | 63.5K | 98.0K | 61.4K | 70.0K |
| Total assets | 5.26M | 4.22M | 9.50M | 3.29M | 2.09M |
| Accounts payable | 318.3K | 318.7K | 448.2K | 631.4K | 694.7K |
| Current liabilities | 4.86M | 3.70M | 1.75M | 1.83M | 3.47M |
| Total liabilities | 5.04M | 4.02M | 2.19M | 3.06M | 8.15M |
| Shareholders' equity | 226.1K | 205.2K | 7.32M | 230.6K | -6.06M |
| Shares outstanding | 3.19M | 1.12M | 676.6K | 101.3K | 3.32M |
Cash flow
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Cash from operations | -7.43M | -7.41M | -6.07M | -5.77M | -3.64M |
| Capital spending | -3.55K | -3.16K | -64.5K | -18.3K | -1.93K |
| Free cash flow | -7.43M | -7.42M | -6.13M | -5.79M | -3.65M |
| Cash from investing | -44.5K | -30.2K | -125.3K | -18.3K | -1.93K |
| Cash from financing | 8.03M | 2.73M | 10.3M | 6.53M | 3.84M |
| Change in cash | 558.7K | -4.71M | 4.15M | 742.2K | 194.8K |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 8-K · Current report | Nov 19, 2026 | Meeting outcome | SEC |
| 424B5 · Prospectus | Nov 19, 2026 | Offer document | SEC |
| DEFA14A · Additional proxy material | Nov 19, 2026 | Meeting notice | SEC |
| 8-K · Current report | Nov 19, 2026 | Material contract | SEC |
| DEFA14A · Additional proxy material | Nov 19, 2026 | Meeting notice | SEC |
| EFFECT · Notice that a registration is effective | Nov 19, 2026 | Other filings | SEC |
| DEFA14A · Additional proxy material | Nov 18, 2026 | Meeting notice | SEC |
| S-3/A · Registration statement, amended | Nov 17, 2026 | Offer document | SEC |
| DEFA14A · Additional proxy material | Nov 17, 2026 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Nov 13, 2026 | Meeting notice | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| DEFA14A · Additional proxy material | Nov 13, 2026 | Meeting notice | SEC |
| 8-K/A · Current report, amended | Nov 13, 2026 | Current report | SEC |
| DEFA14A · Additional proxy material | Nov 12, 2026 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Nov 10, 2026 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Nov 10, 2026 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Nov 10, 2026 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Nov 9, 2026 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Nov 6, 2026 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Nov 6, 2026 | Meeting notice | SEC |
| 8-K · Current report | Nov 6, 2026 | Current report | SEC |
| DEFA14A · Additional proxy material | Nov 5, 2026 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Nov 4, 2026 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Nov 3, 2026 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Nov 2, 2026 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Oct 30, 2026 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Oct 29, 2026 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Oct 28, 2026 | Meeting notice | SEC |
| SCHEDULE 13G · Big-stake notice | Oct 28, 2026 | Big-stake notice | SEC |
| DEFA14A · Additional proxy material | Oct 27, 2026 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Oct 26, 2026 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Oct 26, 2026 | Meeting notice | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | Oct 23, 2026 | Big-stake notice | SEC |
| DEFA14A · Additional proxy material | Oct 21, 2026 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Oct 19, 2026 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Oct 19, 2026 | Meeting notice | SEC |
| DEFM14A | Oct 19, 2026 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Oct 15, 2026 | Meeting notice | SEC |
| 424B5 · Prospectus | Oct 9, 2026 | Offer document | SEC |
| DEFA14A · Additional proxy material | Oct 6, 2026 | Meeting notice | SEC |
| 8-K · Current report | Oct 6, 2026 | Current report | SEC |
| DEFA14A · Additional proxy material | Oct 6, 2026 | Meeting notice | SEC |
| PRER14A | Oct 5, 2026 | Other filings | SEC |
| DEFA14A · Additional proxy material | Oct 2, 2026 | Meeting notice | SEC |
| 8-K · Current report | Oct 2, 2026 | Material contract | SEC |
| DEFA14A · Additional proxy material | Sep 30, 2026 | Meeting notice | SEC |
| S-3 · Registration statement | Sep 25, 2026 | Offer document | SEC |
| DEFA14A · Additional proxy material | Sep 24, 2026 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Sep 21, 2026 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Sep 18, 2026 | Meeting notice | SEC |
| PRER14A | Sep 17, 2026 | Other filings | SEC |
| DEFA14A · Additional proxy material | Sep 17, 2026 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Sep 17, 2026 | Meeting notice | SEC |
| 8-K · Current report | Sep 17, 2026 | Current report | SEC |
| DEFA14A · Additional proxy material | Sep 16, 2026 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Sep 15, 2026 | Meeting notice | SEC |
| 8-K · Current report | Sep 15, 2026 | Results | SEC |
| DEFA14A · Additional proxy material | Sep 15, 2026 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Sep 14, 2026 | Meeting notice | SEC |
| 10-Q · Quarterly report | Sep 14, 2026 | Quarterly report | SEC |
| DEFA14A · Additional proxy material | Sep 11, 2026 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Sep 10, 2026 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Sep 10, 2026 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Sep 9, 2026 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Sep 9, 2026 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Sep 8, 2026 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Sep 8, 2026 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Sep 4, 2026 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Sep 4, 2026 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Sep 3, 2026 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Sep 2, 2026 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Sep 1, 2026 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Aug 31, 2026 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Aug 31, 2026 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Aug 28, 2026 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Aug 27, 2026 | Meeting notice | SEC |
| S-8 · Registration statement for employee plans | Aug 25, 2026 | Offer document | SEC |
| DEFA14A · Additional proxy material | Aug 25, 2026 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Aug 24, 2026 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Aug 21, 2026 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Aug 20, 2026 | Meeting notice | SEC |
| 8-K · Current report | Aug 20, 2026 | Current report | SEC |
| DEFA14A · Additional proxy material | Aug 19, 2026 | Meeting notice | SEC |
| 8-K/A · Current report, amended | Aug 19, 2026 | Current report | SEC |
| DEFA14A · Additional proxy material | Aug 19, 2026 | Meeting notice | SEC |
| 8-K · Current report | Aug 19, 2026 | Current report | SEC |
| SCHEDULE 13D · Big-stake notice | Aug 18, 2026 | Big-stake notice | SEC |
| DEFA14A · Additional proxy material | Aug 18, 2026 | Meeting notice | SEC |
| 8-K · Current report | Aug 18, 2026 | Material contract | SEC |
| DEFA14A · Additional proxy material | Aug 7, 2026 | Meeting notice | SEC |
| 8-K · Current report | Aug 7, 2026 | Current report | SEC |
| DEFA14A · Additional proxy material | Aug 6, 2026 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Aug 4, 2026 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Jul 30, 2026 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Jul 29, 2026 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Jul 29, 2026 | Meeting notice | SEC |
| 8-K · Current report | Jul 29, 2026 | Results | SEC |
| DEFA14A · Additional proxy material | Jul 28, 2026 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Jul 28, 2026 | Meeting notice | SEC |
| PREM14A | Jul 27, 2026 | Other filings | SEC |
| DEFA14A · Additional proxy material | Jul 27, 2026 | Meeting notice | SEC |
| 8-K/A · Current report, amended | Jul 27, 2026 | Current report | SEC |
| DEFA14A · Additional proxy material | Jul 27, 2026 | Meeting notice | SEC |
| 8-K · Current report | Jul 27, 2026 | Material contract | SEC |
| DEFA14A · Additional proxy material | Jul 23, 2026 | Meeting notice | SEC |
| 8-K · Current report | Jul 23, 2026 | Current report | SEC |
| 10-K · Annual report | Jul 23, 2026 | Annual report | SEC |
| DEFA14A · Additional proxy material | Jul 22, 2026 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Jul 10, 2026 | Meeting notice | SEC |
| 8-K · Current report | Jul 10, 2026 | Management or board change | SEC |
| 4 · Change in ownership | Jul 9, 2026 | Insider trade | SEC |
| DEFA14A · Additional proxy material | Jun 26, 2026 | Meeting notice | SEC |
| 8-K · Current report | Jun 26, 2026 | Management or board change | SEC |
| DEFA14A · Additional proxy material | Jun 26, 2026 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Jun 26, 2026 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Jun 25, 2026 | Meeting notice | SEC |
| 4 · Change in ownership | Jun 24, 2026 | Insider trade | SEC |
| DEFA14A · Additional proxy material | Jun 24, 2026 | Meeting notice | SEC |
| SCHEDULE 13G · Big-stake notice | Jun 24, 2026 | Big-stake notice | SEC |
| DEFA14A · Additional proxy material | Jun 23, 2026 | Meeting notice | SEC |
| 8-K · Current report | Jun 23, 2026 | Current report | SEC |
| DEFA14A · Additional proxy material | Jun 23, 2026 | Meeting notice | SEC |
| 8-K · Current report | Jun 23, 2026 | Material contract | SEC |
| 253G2 | Jun 1, 2026 | Other filings | SEC |
| 8-K · Current report | May 6, 2026 | Meeting outcome | SEC |
| QUALIF | Apr 20, 2026 | Other filings | SEC |
| 253G2 | Apr 17, 2026 | Other filings | SEC |
| 1-A POS | Apr 10, 2026 | Other filings | SEC |
| 8-K · Current report | Apr 3, 2026 | Management or board change | SEC |
| DEFA14A · Additional proxy material | Mar 19, 2026 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Mar 17, 2026 | Meeting notice | SEC |
| 8-K · Current report | Mar 16, 2026 | Results | SEC |
| 10-Q · Quarterly report | Mar 16, 2026 | Quarterly report | SEC |
| PRE 14A · Preliminary proxy statement | Mar 6, 2026 | Meeting notice | SEC |
| 8-K · Current report | Jan 16, 2026 | Material contract | SEC |
| 4 · Change in ownership | Jan 12, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 12, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Dec 22, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 22, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 22, 2025 | Insider trade | SEC |
| 8-K · Current report | Dec 16, 2025 | Material contract | SEC |
| 8-K · Current report | Dec 15, 2025 | Results | SEC |
| 10-Q · Quarterly report | Dec 15, 2025 | Quarterly report | SEC |
| 4 · Change in ownership | Nov 28, 2025 | Insider trade | SEC |
| 8-K · Current report | Nov 28, 2025 | Management or board change | SEC |
| S-8 · Registration statement for employee plans | Nov 5, 2025 | Offer document | SEC |
| 8-K · Current report | Oct 1, 2025 | Material contract | SEC |
| 8-K · Current report | Sep 17, 2025 | Current report | SEC |
| 8-K · Current report | Sep 11, 2025 | Results | SEC |
| 10-Q · Quarterly report | Sep 11, 2025 | Quarterly report | SEC |
| 8-K · Current report | Sep 5, 2025 | Current report | SEC |
| 8-K · Current report | Aug 22, 2025 | Current report | SEC |
| 424B5 · Prospectus | Aug 4, 2025 | Offer document | SEC |
| 8-K · Current report | Aug 4, 2025 | Material contract | SEC |
| 4 · Change in ownership | Jul 30, 2025 | Insider trade | SEC |
| 8-K · Current report | Jul 30, 2025 | Current report | SEC |
| 144 · Notice of proposed sale | Jul 29, 2025 | Other filings | SEC |
| 8-K · Current report | Jul 24, 2025 | Results | SEC |
| 10-K · Annual report | Jul 24, 2025 | Annual report | SEC |
| 8-K · Current report | Jul 21, 2025 | Current report | SEC |
| 4 · Change in ownership | Jul 14, 2025 | Insider trade | SEC |
| 8-K · Current report | Jul 14, 2025 | Material contract | SEC |
| 4 · Change in ownership | Jul 11, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 11, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 11, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 11, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 11, 2025 | Insider trade | SEC |
| 8-K · Current report | Jul 1, 2025 | Current report | SEC |
| 8-K · Current report | Jun 4, 2025 | Current report | SEC |
| 8-K · Current report | Jun 3, 2025 | Material contract | SEC |
| 8-K · Current report | Jun 3, 2025 | Current report | SEC |
| 8-K · Current report | May 28, 2025 | Current report | SEC |
| 8-K · Current report | May 19, 2025 | Current report | SEC |
| 253G2 | May 15, 2025 | Other filings | SEC |
| 8-K · Current report | Mar 21, 2025 | Current report | SEC |
| 8-K · Current report | Mar 13, 2025 | Results | SEC |
| 10-Q · Quarterly report | Mar 13, 2025 | Quarterly report | SEC |
| 253G2 | Mar 11, 2025 | Other filings | SEC |
| QUALIF | Mar 11, 2025 | Other filings | SEC |
| CORRESP · Letter to the SEC | Mar 6, 2025 | Other filings | SEC |
| 1-A/A | Feb 28, 2025 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Feb 21, 2025 | Other filings | SEC |
| 1-A | Feb 12, 2025 | Other filings | SEC |
| 4 · Change in ownership | Jan 23, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 21, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 21, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 21, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 21, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 21, 2025 | Insider trade | SEC |
| 8-K · Current report | Jan 21, 2025 | Management or board change | SEC |
| RW · Request to withdraw a registration | Dec 19, 2024 | Other filings | SEC |
| 8-K · Current report | Dec 17, 2024 | Current report | SEC |
| RW · Request to withdraw a registration | Dec 17, 2024 | Other filings | SEC |
| 8-K · Current report | Dec 16, 2024 | Results | SEC |
| 10-Q · Quarterly report | Dec 16, 2024 | Quarterly report | SEC |
| 8-K · Current report | Nov 8, 2024 | Meeting outcome | SEC |
| 8-K/A · Current report, amended | Oct 21, 2024 | Current report | SEC |
| 8-K · Current report | Oct 18, 2024 | Current report | SEC |
| S-1/A · Registration statement, amended | Sep 27, 2024 | Offer document | SEC |
| DEFA14A · Additional proxy material | Sep 26, 2024 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Sep 18, 2024 | Meeting notice | SEC |
This page holds 200 of 366 filings. Open Filings
Cap table
Built by 6ix from HeartSciences Inc.’s releases · as of Sep 15, 2026
- Common shares
- 4,969,283
- Fully diluted
- 4,969,283
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 4,969,283 | Aug 12, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Aug 12, 2026 | 4,969,283 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| David R. Wells Other companies: Fusemachines Inc. (Chief Financial Officer · Since at least Sep 1, 2026); Functional Brands, Inc. (Chief Financial Officer, Director · Since at least May 18, 2026); Envoy Medical, Inc. (Chief Financial Officer · Sep 29, 2023 – Oct 15, 2023 · Past); ENDRA Life Sciences Inc. (Chief Financial Officer · May 8, 2017 – Apr 5, 2021 · Past); Sionix Corporation (President, CFO, Director · Dec 16, 2009 – May 7, 2012 · Past) | Board Member · Since at least Dec 28, 2022 |
| Bruce Bent Other companies: Astro Aerospace Ltd (Director · Mar 14, 2018 – Mar 4, 2021 · Past) | Board Member · Since at least Jun 14, 2022 |
| Aaron Peterson | VP, Research & Development · Since at least Nov 4, 2026 |
| Andrew Simpson | Chairman and CEO / Board Member · Since at least Jun 14, 2022 |
| Brian Szymczak | Director · Since at least Jun 14, 2022 |
| Danielle Watson | Chief Financial Officer · Since at least Nov 4, 2026 |
| Isabella Schmitt | VP, Clinical & Regulatory Affairs · Since at least Nov 4, 2026 |
| Jason Domask | VP of Software Engineering & MyoVista Insights™ Product Owner · Since at least Nov 4, 2026 |
| Mark T Hilz | See Remarks · Since at least Jun 14, 2022 |
| Patrick Kanouff | Director · Jun 14, 2022 – Jun 14, 2022 · Past |
Log in to ask 6ix AI your own questions about HeartSciences Inc.